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ABSTRACT Intercellular adhesion mediated by integrin a4b1 and vascular cell adhesion molecule-1 (VCAM-1) plays a crucial
role in both the rolling and ﬁrm attachment of leukocytes onto the vascular endothelium. Essential to the a4b1/VCAM-1
interaction is its mechanical strength that allows the complex to resist the large shear forces imposed by the bloodstream.
Herein we employed single-molecule dynamic force spectroscopy to investigate the dynamic strength of the a4b1/VCAM-1
complex. Our force measurements revealed that the dissociation of the a4b1/VCAM-1 complex involves overcoming at least two
activation potential barriers: a steep inner barrier and a more elevated outer barrier. The inner barrier grants the complex the
tensile strength to withstand large pulling forces (.50 pN) and was attributed to the ionic interaction between the chelated Mg21
ion at the N-terminal A-domain of the b1 subunit of a4b1 and the carboxyl group of Asp-40 of VCAM-1 through the use of site-
directed mutations. In general, additional mutations within the C-D loop of domain 1 of VCAM-1 suppressed both inner and
outer barriers of the a4b1/VCAM-1 complex, while a mutation at Asp-143 of domain 2 of VCAM-1 resulted in the suppression of
the outer barrier, but not the inner barrier. In contrast, the outer barrier of a4b1/VCAM-1 complex was stabilized by integrin
activation. Together, these ﬁndings provide a molecular explanation for the functionally relevant kinetic properties of the a4b1/
VCAM-1 interaction.
INTRODUCTION
To serve their functions, blood leukocytes must leave
systemic circulation and migrate into lymphoid tissues or to
the sites of inﬂammation. This process, termed extravasation,
is mediated by the adhesive interactions between molecules
present on leukocytes and their counterreceptors expressed
on the vascular endothelium (Springer, 1990). Among these
interactions, the adhesion complex formed by leukocyte
integrin a4b1 (very late antigen-4, VLA-4) and its endo-
thelial ligand vascular cell adhesion molecule-1 (VCAM-1)
is essential for the extravasation of many leukocyte subtypes
(Kubes, 2002).
Integrin a4b1 is formed by the noncovalent association of
the integrin a4 (molecular mass ;155 kDa) and b1 (mole-
cular mass ;150 kDa) subunits (Hemler et al., 1987). a4b1
is expressed on most leukocytes, including lymphocytes,
mast cells, eosinophils, natural killer cells, and monocytes.
a4b1 has two known ligands, VCAM-1 and the extracellular
matrix protein, ﬁbronectin. VCAM-1 is expressed on en-
dothelial cells in two alternately spliced forms, a major form
consisting of seven Ig-like domains (VCAM-1(7D)) and a
minor form, lacking domain 4 (Osborn et al., 1994). VCAM-
1(7D) has two homologous binding sites for a4b1. One site
has been localized to domains 1 and 2 and the second to
domains 4 and 5. The binding of a4b1 to VCAM-1 involves
contributions from the N-terminal domains of both a4 and
b1 subunits of a4b1. The b1 A-domain contains a metal ion-
dependent adhesion site (MIDAS) that has been implicated
in VCAM-1 binding (Vonderheide et al., 1994). In addition,
repeats 2–4 of the N-terminal seven-bladed b-propeller do-
main of a4 have also been shown to be important for VCAM-1
binding. The most crucial interaction in the stabilization of
the a4b1/VCAM-1 complex appears to be the electrostatic
interaction between Asp-40 of domain 1 (D1) of VCAM-1
and the chelated Mg21 ion of the b1 A-domain. Besides
Asp-40, other residues that are part of the C-D loop (i.e.,
T37QIDSPLN) of D1 of VCAM-1 have been shown to be
important in a4b1 binding (Vonderheide et al., 1994). In
addition, recent studies suggested that domain 2 of VCAM-1
is also involved in stabilizing the a4b1/VCAM-1 complex
(Newham et al., 1997).
The main purpose of this research is to understand the
molecular basis by which the a4b1/VCAM-1 interaction is
able to resist a pulling force. Such studies provide important
insight into how activated leukocytes are able to remain
adherent to the endothelium in the presence of the shear force
of the bloodstream. Although the equilibrium binding af-
ﬁnity constant of the a4b1/VCAM-1 complex has been
measured by competitive binding assays (Chigaev et al.,
2003), these measurements cannot be used to extrapolate the
unbinding force of the complex (Moy et al., 1994). To access
the mechanical properties of the a4b1/VCAM-1 complex, we
have employed the atomic force microscope (AFM) (Binnig
et al., 1986; Ho¨rber and Miles, 2003; Radmacher et al., 1992)
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to measure the loading rate dependence of complex
unbinding (i.e., its dynamic force spectrum (DFS)) (Merkel
et al., 1999) and to characterize the dissociation potential of
the complex. Subsequent mutagenesis experiments permitted
us to correlate molecular determinants in VCAM-1 to
features in the dissociation potential of the complex.
METHODS
Reagents
a4b1-Fc was generated and puriﬁed according to Stephens et al. (2000). To
avoid the complicity of two different binding sites on VCAM-1(7D) in our
experiments, we used a recombinant truncated form of VCAM-1 containing
only the ﬁrst two domains, VCAM-1(2D)Fc (Newham et al., 1997). VCAM-
1(2D)Fc mutants were generated by the method of Kunkel et al. (1987) and
have been described earlier (Newham et al., 1997). Puriﬁed VCAM-1(2D)Fc
was isolated from COS-1 cells transfected with the pIg-VCAM cDNA.
Human function-blocking antibody AF809 (anti-VCAM-1) was purchased
from R & D Systems (Minneapolis, MN). All other reagents were from
Sigma (St. Louis, MO).
Force apparatus
All single-molecule force measurements were conducted using a home-built
AFM that employs a single axis piezoelectric translator equipped with
a strain gauge (Physik Instrumente, Waldbronn, Germany) to control the
absolute position of the AFM cantilever (Chen and Moy, 2002). The
deﬂection of the cantilever was monitored optically by using an inverted
optical system attached to the AFM. A focused laser spot from a ﬁber-
coupled diode laser (Oz Optics, Nepean, ON, Canada) was reﬂected off the
back of the cantilever onto a two-segment photodiode to monitor the
cantilever’s deﬂection. The photodiode signal was preampliﬁed, digitized,
and processed by an Apple Power Macintosh computer. The sample holder
of the apparatus was designed to accept a standard 35-mm tissue culture
dish. The force apparatus was suspended within a refrigerator housing to
reduce both mechanical and thermal instabilities.
Attachment of live cells to the AFM cantilever
The human monocytic cell line U937 (ATCC, Manassas, VA) was
maintained in RPMI 1640 medium supplemented with 10% fetal bovine
serum, 1% glutamine, 50 U/mL penicillin, and 50 mg/mL streptomycin in
5% CO2 at 37C until needed. Individual U937 cells were attached to the
AFM cantilever via concanavalin A (Con A)-mediated linkages (Benoit,
2002; Zhang et al., 2002). To prepare the Con A-functionalized cantilever,
the cantilevers were soaked in acetone for 5 min, ultraviolet-irradiated for 30
min, and incubated in biotinamidocaproyl-labeled bovine serum albumin
(BSA) (biotin-BSA, 0.5 mg/mL in 100 mM NaHCO3, pH 8.6) overnight at
37C. The cantilevers were then rinsed three times with PBS (10 mM PO43-,
150 mM NaCl, pH 7.3) and incubated in streptavidin (0.5 mg/mL in
phosphate-buffered saline (PBS)) for 10 min at room temperature. After the
removal of unbound streptavidin, the cantilevers were incubated in
biotinylated Con A (0.5 mg/mL in PBS) and then rinsed with PBS. To
attach the cell to the cantilever, the tip of the Con A-functionalized cantilever
was positioned above the center of a cell and lowered onto the cell for;1 s.
AFM measurements using the U937 functionalized cantilever were carried
out in complete culture medium supplemented with 10 mM HEPES.
AFM measurements
The AFM force measurements were performed at room temperature (25C)
in force spectroscopy mode. The AFM force measurements consisted of an
approach trace that recorded the force acting on the cantilever while the
cantilever was lowered onto the sample, and a retraction trace that recorded
the tip/sample interaction while the cantilever was pulled away from the
sample. Measurements of unitary unbinding forces were obtained under
conditions that minimized contact between the functionalized cantilever and
the sample. An adhesion frequency of ,30% in the force measurements
ensured a.83% probability that the adhesion event wasmediated by a single
bond (Evans et al., 2001; Tees et al., 2001). The concentrations of proteins
used in the preparation of the cantilever and substrate were adjusted to
achieve adhesion frequencies of 20–30%. Measurements were acquired for
loading rates between 100 pN/s and 100,000 pN/s. The change of loading
rates was achieved by varying the retraction speed of the cantilever from
0.03 to 30 mm/s. Cantilevers were calibrated by equating their thermal
vibrational energy to that of a one-dimensional oscillator (Hutter and
Bechhoefer, 1993). The spring constants (;10 mN/m) of the calibrated
cantilevers agreed with the values speciﬁed by the manufacturer.
The unbinding forces of individual adhesive interactions were derived
from the jump in force after the separation of the cantilever from the
sample. We acquired 50–150 unbinding forces for each histogram. For
measurements obtained at fast retraction rates (.1 mm/s), the measured
unbinding force was corrected for hydrodynamic drag acting on the
cantilever. The determination of hydrodynamic forces was based on amethod
used by Tees et al. (2001). We allowed the cantilever to undergo free
movement at different speeds, and the hydrodynamic force for each speed
was measured. The damping coefﬁcient of the cantilever in the experimental
solution was ;2 pN-s/mm.
Dynamic force spectroscopy
Our analysis of the unbinding of the a4b1/VCAM-1 complex employed the
Bell-Evans model (Bell, 1978; Evans and Ritchie, 1997), which has been
applied to studies of other ligand-receptor systems (Chen and Springer,
2001; Evans et al., 2001; Merkel et al., 1999). In the context of this model,
a pulling force f distorts the energy landscape of the ligand-receptor
complex, resulting in a lowering of the activation barrier(s), and
consequently increases the dissociation rate constant k(f) as follows:
kð f Þ ¼ k0 exp½ fg=kBT; (1)
where k0 is the dissociation rate constant in the absence of the pulling force,
g is the width of the potential barrier projected along the direction of the
applied force, T is absolute temperature, and kB is Boltzmann’s constant.
Under conditions of a constant loading rate rf (rf ¼ df/dt), the probability
density function for the unbinding of a complex at force f is given by (Evans
and Ritchie, 1997):
Pð f Þ ¼ k0 exp gf
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Hence, Eq. 3 shows that the most probable unbinding force f * is a linear
function of the logarithm of the loading rate. Experimentally, the most
probable unbinding force f * was obtained from the mode of the unbinding
force histogram. The Bell model parameters k0 and g were obtained from the
plot of f * versus ln(rf).
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RESULTS
Dynamic strength of the a4b1/VCAM-1 complex
Single-molecule AFM force measurements (Florin et al.,
1994; Lee et al., 1994) were carried out to characterize the
dynamic strength of the a4b1/VCAM-1 interaction. Fig. 1 A
illustrates our experimental system, which consisted of an
AFM cantilever decorated with recombinant a4b1-Fc and
puriﬁed VCAM-1(2D)Fc immobilized on a tissue culture
dish. a4b1-Fc is a soluble form of human a4b1, produced
as a Fc chimera after fusion of the cDNAs encoding the
ectodomains of each subunit to genomic DNA encoding the
Fc of human g1 IgG (Stephens et al., 2000). Both a4b1-Fc
and native a4b1 bind VCAM-1 with an apparent Kd of
0.2–0.3 nM (Stephens et al., 2000). VCAM-1(2D)Fc is a
recombinant truncated form of VCAM-1 consisting of do-
mains 1 and 2 of human VCAM-1 fused to the hinge of the
Fc region of human IgG1.
To assess the dynamic strength of individual a4b1-Fc/
VCAM-1(2D)Fc interactions, contact between the cantilever
tip and substrate was minimized by using a small contact
duration (,50 ms) and a small compression force (;100
pN). Fig. 1 B plots a series of eight AFM recordings of the
interaction between AFM tip and substrate. Adhesion
between the apposing surfaces on contact gave rise to
a hysteresis between the approach (shaded) and retraction
(black) traces of the measurement, as found in the second,
sixth, and eighth traces of Fig. 1 B. The unbinding force fu of
the a4b1-Fc/VCAM-1(2D)Fc complex is derived from the
force jump that accompanies the unbinding of the complex.
Sample force histograms of unbinding force obtained with
different loading rates are presented in Fig. 1 C. These
histograms show that the unbinding force increases with the
loading rate of the measurements. The DFS of the a4b1-Fc/
VCAM-1(2D)Fc interaction was obtained by plotting the
mode unbinding force as a function of loading rate as shown
in Fig. 2 A. The speciﬁcity of the a4b1-Fc/VCAM-1(2D)Fc
interactions was conﬁrmed by a reduction in the frequency of
adhesion after the addition of a function-blocking antibody
against VCAM-1 (e.g., AF809) or free VCAM-1(2D)Fc
molecules (Fig. 2 B). To test whether the adsorbed VCAM-
1(2D)Fc was pulled off the substrate rather than separating
FIGURE 1 AFM force measurements of the a4b1-Fc/VCAM-1(2D)Fc
interaction. (A) Schematic of the experimental system. a4b1-Fc was coupled
to the AFM cantilever via a glutaraldehyde linkage (Moy et al., 1999). The
cantilevers were initially silanized with 3-aminopropyltriethoxysilane to
introduce an amino group on the cantilever surface. After incubation of the
cantilevers with 0.1% glutaraldehyde for 30 min, a4b1-Fc (100–200 mg/ml)
was coupled to the cantilever through the glutaraldehyde linker. BSA (100
mg/mL) in Tris buffered saline (30 mM Tris, 150 mM NaCl, pH 7.5) was
used to block the bare surfaces of the cantilever. VCAM-1(2D)/Fc was
immobilized onto the Petri dish by passive adsorption (Wojcikiewicz et al.,
2003; Zhang et al., 2002). Thirty mL of VCAM-1(2D)/Fc at 5 mg/ml in 0.1
M NaHCO3 (pH 8.6) was adsorbed overnight at 4C on the center of a 35-
mm tissue culture dish (Falcon, BD Biosciences, San Jose, CA). Higher
protein concentrations (20–100 mg/ml) were used in the VCAM-1 mutant
experiments. Before each experiment, both the functionalized cantilever and
the coated dish were blocked with BSA at 100 mg/mL. (B) A series of eight
consecutive AFM force-displacement curves. The AFMmeasurements were
acquired with an adhesion frequency of;30% in Tris-buffered saline plus 2
mM of Mg21. fu is the unbinding force of the a4b1/VCAM-1 complex. ks is
the system spring constant and was derived from the slope of the force-
displacement trace. The speed of cantilever retraction was 1300 nm/s. The
force loading rate was ;5 nN/s. (C) Force histograms of unitary a4b1-Fc/
VCAM-1(2D)Fc unbinding forces for three different loading rates.
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from the a4b1-Fc of the AFM tip during our measurements,
we covalently coupled VCAM-1(2D)Fc to a glass coverslip
(Moy et al., 1999). As shown in the insert of Fig. 2 A, the
covalent immobilization method and the passive adsorption
method yielded indistinguishable DFS, thus conﬁrming that
the measured rupture forces correspond to the unbinding of
the a4b1-Fc/VCAM-1(2D)Fc complex.
As shown in Fig. 2 A, a4b1-Fc/VCAM-1(2D)Fc force
spectra can be divided into two regimes within the range of
loading rates accessible by our instrument. Beginning at 150
pN/s, the unbinding force increased exponentially with
loading rate up to ;20,000 pN/s. Beyond this point, a faster
exponential increase is clearly evident. A theoretical
framework for understanding how a pulling force affects
the dissociation rate of adhesion complex was proposed by
Bell (1978). In this model, the dissociation potential of an
adhesion complex is characterized by two parameters: k0 is
the dissociation rate constant in the absence of force and g is
the position of the transition state of the complex. Recently,
Evans showed that molecular dissociation of a complex that
involves overcoming more than one activation barrier may
result in a DFS that reveals several exponential domains
distinguishable by differences in slopes (Evans and Ritchie,
1997; Merkel et al., 1999). Our DFS of the a4b1-Fc/VCAM-
1(2D)Fc interaction is consistent with an intermolecular
potential that includes two activation energy barriers. The
barriers are characterized by two force-loading regimes in
the DFS: slow (150–20,000 pN/s) and fast (20,000–100,000
pN/s) (Fig. 2 A). Fitting Eq. 3 (see Methods) to the slow and
fast regimes gives the Bell model parameters (i.e., k0 and g)
for outer and inner barriers, respectively (see Table 1). Based
on this analysis, the estimated widths of the inner and outer
barriers are ;1 and 5.9 A˚, respectively.
Contributions of D1 of VCAM-1
Previous studies suggest that divalent cations are essential
for the formation of the inner barrier of both a5b1/ﬁbronectin
and aLb2/ICAM-1 complexes (Li et al., 2003; Zhang et al.,
2002). Likewise, the a4b1/VCAM-1 interaction involves
a Mg21 ion that is chelated by the MIDAS site of the b
A-domain and interacts with the Asp-40 residue in domain 1
of VCAM-1 (Wang and Springer, 1998). Hence, we postulate
that the inner barrier in the a4b1/VCAM-1 interaction is
largely due to the strong ionic interaction between the
chelated Mg21 and the negatively charged Asp-40 residue.
Indeed, the presence of 5 mM EDTA eliminated the inner
activation barriers of the a4b1/VCAM-1 complex (Fig. 3), as
previously observed in the aLb2/ICAM-1 interaction.
However, this EDTA effect could be due to a direct or
FIGURE 2 Dynamic force spectroscopy of the a4b1-Fc/VCAM-1(2D)Fc
interaction. (A) Dynamic force spectra of the a4b1/VCAM-1 complexes in 2
mM Mg21. The most probable unbinding forces were obtained from the
mode of the unbinding-force histogram, i.e., the tallest bin in the histogram.
The best-ﬁt curves (solid lines) were obtained using Eq. 3. (Inset) Different
immobilization method of VCAM-1 (circles, passive adsorption; triangles:
covalent linkage). Error bars indicate the standard error of the mean. Some
error bars are within the symbol. (B) Adhesion frequency in AFM
measurements of the a4b1/VCAM-1 interactions under different conditions.
Error bars indicate standard error of the mean. The ﬁnal concentrations of
AF809 (anti-VCAM-1) and free VCAM-1(2D)Fc used in the inhibition
experiments were both 50 mg/mL.
TABLE 1 Bell model parameters of the
a4b1/VCAM-1 complexes
Condition g1(A˚) k
0
1ðs1Þ g2(A˚) k02ðs1Þ
Wild-type 1.0 6 0.1 59 6 7 5.9 6 0.2 0.13 6 0.02
5 mM EDTA — — 3.8 6 0.3 9.3 6 0.4
D40A — — 5.9 6 0.4 1.2 6 0.3
D40E 2.7 6 0.1 16 6 2 5.5 6 0.1 1.0 6 0.3
Q38G 1.7 6 0.1 65 6 10 5.8 6 0.2 0.46 6 0.06
L43K 1.5 6 0.1 60 6 8 5.7 6 0.1 1.7 6 0.4
D143A 0.95 6 0.05 72 6 4 5.8 6 0.1 0.85 6 0.05
The Bell model parameters were given by ﬁtting Eq. 3 to the acquired
measurements. Linear regression was done using IgorPro software. The
indices 1 and 2 in the subscript of the Bell model parameters refer to the
inner and outer barriers of the complex, respectively. The goodness of ﬁt
was determined by R2, the square of the correlation coefﬁcient. An R2 of
0.95 was chosen as the cutoff point to determine the transition point
between the slow and the fast loading regimes.
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indirect contribution of the divalent cation to the formation
of the inner activation barrier since it is conceivable that the
b A-domain is not folded properly in the absence of Mg21.
To further investigate the nature of divalent cation action, we
investigated the interaction between a4b1 and two VCAM-1
mutants that have a single amino acid substitution at the Asp-
40 residue. Mutating the Asp-40 residue of VCAM-1 to the
neutral residue, alanine (D40A), suppressed the unbinding
forces of the a4b1/VCAM-1 interaction, most noticeably in
the high loading regime of the DFS (Fig. 3). However, when
Asp-40 is substituted by the negatively charged residue
glutamate (D40E), the fast loading regime is still distinguish-
able from the slow loading regime, indicating that the inner
activation barrier is suppressed, but not eliminated.
A more detailed analysis of the measurements on the
VCAM-1 mutants was achieved by ﬁtting the Bell model to
the acquired DFS. Table 1 summarizes the Bell model
parameters for the different a4b1/VCAM-1 (mutants) com-
plexes. Both EDTA treatment and the D40A mutation com-
pletely eliminated the inner activation barrier, whereas the
D40E mutation widened the inner barrier from 1 A˚ to 2.7 A˚.
As discussed below, the consequence of this widening of the
inner barrier is that the dissociation rate of the complex
becomes more responsive to changes in pulling force in the
high force regime. The effects of EDTA treatment and both
D40 mutations on the outer activation barrier were similar,
resulting in a suppression of the outer barrier as indicated by
the 10-fold increase in the dissociation rate for the outer
barrier. Taken together, these data demonstrate that the inner
barrier of the a4b1-Fc/VCAM-1(2D)Fc complex requires
both the divalent cation Mg21 and the Asp-40 residue of
VCAM-1. The absence of this ionic interaction also
destabilized the outer activation barrier.
In addition to Asp-40, we also explored the role of other
residues in the C-D loop of the ﬁrst domain of VCAM-1,
including Gln-38 and Leu-43. Fig. 4 A shows that the two
C-D loop mutants Q38G and L43K yielded similar DFS.
Compared with the wild-type VCAM-1, these mutants have
smaller unbinding forces in both the slow and fast loading
regimes. The Bell model parameters of these two mutants
reveal that the reduced unbinding forces are largely due to
a widening in the inner barrier and a suppression in the
height of the outer barrier (i.e., larger k02). Differences in the
dynamic strength of our C-D loop mutants (i.e., D40A,
D40E, Q38G, and L43K) appears to be due to a difference in
the width of the inner barrier (i.e., g1).
FIGURE 3 Molecular determinants of the inner activation barriers of the
a4b1-Fc/VCAM-1(2D)Fc complex. Effects of EDTA and mutations in the
Asp-40 residue of VCAM-1. Error bars indicate standard error of the mean.
When not visible, error bars are within the symbol.
FIGURE 4 Molecular determinants of the outer activation barriers of the
a4b1-Fc/VCAM-1(2D)Fc complex. (A) Effect of mutations in the C-D loop
of VCAM-1. (B) Effect of mutations in the D2 of VCAM-1. Error bars
indicate standard error of the mean. When not visible, error bars are within
the symbol.
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Contributions of D2 of VCAM-1
Newham et al. have shown that certain mutations in the D2
of VCAM-1 (i.e., D143A, S148A, and E150A) also affected
binding to a4b1 (Newham et al., 1997). These mutations
were previously identiﬁed as having a marked effect on the
a4b1 binding, though it is not known how these mutations
modiﬁed a4b1 binding. It has been proposed that the
interaction between D2 of VCAM-1 and a4b1 is analogous
to the interaction between a5b1 and the synergy site in
FNIII9 of ﬁbronectin. We have previously shown that the
synergy site of FNIII9 helps stabilize the outer activation
barrier of the a5b1/ﬁbronectin interaction (Li et al., 2003).
To test if D2 of VCAM-1 has a similar role, we acquired the
DFS of a4b1 interacting with one of the D2 mutants (i.e.,
D143A) and found that the mutation suppressed the
unbinding force in the slow loading regime, but had no
effect on forces in the fast loading regime (Fig. 4 B). A
comparison of the Bell model parameters obtained using
wild-type VCAM-1 and its D143A mutant reveals that the
only difference between the wild-type and mutant inter-
actions is a reduction in the height of the outer activation
barrier of mutant complex. These results suggest that D2 of
VCAM-1 helps stabilize the activation energy of the outer
barrier of the a4b1/VCAM-1 complex.
Dynamic strength of the native a4b1/VCAM-1
complex in live cells
An important attribute of integrins is their ability to modulate
the adhesive states of cells (Diamond and Springer, 1994;
Dustin and Springer, 1989; Humphries et al., 2003; Shimaoka
et al., 2002). In resting leukocytes, a4b1 is expressed in an
inactive, nonadhesive state that binds VCAM-1 with low
afﬁnity. Upon activation, the leukocyte expresses an acti-
vated form ofa4b1 and becomes adherent to the endothelium.
The induction of high-afﬁnity a4b1 is presumably due to the
unclasping and separation of the integrin a andb cytoplasmic
tails, leading to changes in the conformation and/or
orientation of the N-terminal domains of both the a and b
subunits (Carman and Springer, 2003).
To determine if the VCAM-1 binding properties of our
recombinant a4b1-Fc resembles that of native a4b1, we
measured the DFS of a4b1/VCAM-1(2D) interaction on live
U937 cells (Fig. 5 A). U937 is a monocytic cell line that has
been used in previous studies of a4b1 mediated adhesion
(Chigaev et al., 2003). The expression of a4b1 on U937 cells
was conﬁrmed by ﬂow cytometry (data not shown). The
high-afﬁnity form of a4b1 was induced by activation anti-
body TS2/16, bypassing the requirements of inside-out signal
from the cells (Alon et al., 1995; Chen et al., 1999; Li et al.,
2003). As shown in Fig. 5 B, the DFS of native a4b1/
VCAM-1 complexes also displayed two loading regimes,
similar to the results obtained with recombinant a4b1-Fc.
After activation by TS2/16, the unbinding forces of the
native a4b1/VCAM-1(2D) complex were elevated over the
range of loading rates between 100 and 20,000 pN/s, but did
not signiﬁcantly change at loading rates .20,000 pN/s. Fig.
5 B also reveals that the DFS of a4b1-Fc/VCAM-1(2D)Fc
interaction is nearly identical to that of the high-afﬁnity
native a4b1/VCAM-1(2D)Fc interaction. Moreover, the
presence of the TS2/16 antibody did not change the DFS
of the a4b1-Fc/VCAM-1(2D)Fc interaction. Hence, we
conclude that a4b1-Fc is locked in a conformational state
that resembles the high-afﬁnity conformer of native a4b1.
Table 2 lists the Bell model parameters of the native a4b1/
VCAM-1(2D) interaction. The dissociation rates of the outer
barrier for low- and high-afﬁnity a4b1/VCAM-1 complexes
were 1.4/s and 0.035/s, respectively, reﬂecting a difference
in the energy of the outer barrier. However, no signiﬁcant dif-
ference (P . 0.05) was found in dissociation rates (;100/s)
for the inner barrier of both afﬁnity states. Thus, DFS of the
FIGURE 5 DFS of a4b1/VCAM-1 interaction on live U937 cells. (A)
Schematic diagram of the AFM experiments. (B) DFS of the high- and the
low-afﬁnity a4b1/VCAM-1 interaction. The AFM measurements were
acquired under single-molecule conditions. High-afﬁnity a4b1 was induced
by TS2/16. Speciﬁcity of the measurement has been conﬁrmed by antibody
blocking experiments. Error bars indicate standard error of the mean. When
not visible, error bars are within the symbol.
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native a4b1/VCAM-1 interaction shows that induction of
high-afﬁnity a4b1 by TS2/16 elevates the energy potential of
their outer activation barriers, but has minimal effect on the
inner barriers. It should be noted that activation of other
integrins including aLb2 and a5b1 also manifested in an
elevation of the outer activation barrier. Together, these
observations suggest that integrin activation, in general, in-
volves changes in height of the outer activation barrier and
hence the Kd of the complex.
DISCUSSION
Using the k0 and g values from Table 1, we were able to
estimate the energy landscape of the a4b1/VCAM-1
complex. As summarized in Fig. 6 A, the dissociation of
the a4b1/VCAM-1 bond involves overcoming two activation
barriers: a steep inner barrier and a more elevated outer
barrier. The position of the transition states was estimated by
the Bell model parameter g. Estimates of the energy dif-
ference between the transition states were calculated as
DG12 ¼ kBT lnðk01=k02Þ;where k01 and k02 are the dissociation
rate constants of transition states 1 and 2, respectively. The
energy level of the bound complex was arbitrarily chosen.
Mutation at the Asp-40 residue of VCAM-1, i.e., D40A,
eliminated the inner barrier and lowered the outer barrier by
2.3 kBT. The C-D loopmutant L43K lowered the outer barrier
by 3 kBT and widened the inner barrier. However, D143A,
a mutation in the D2 of VCAM-1, did not alter the inner
barrier, but lowered the outer barrier by 2.3 kBT.
The effects of a pulling force on the dissociation rate
constant of a molecular complex with two activation barriers
is given by
koff ¼ 1=fk0
1
1 exp½fg1=kBT1 k0
1
2 exp½fg2=kBTg; (4)
where the subscripts 1 and 2 refer to inner and outer
activation energy barriers, respectively (Evans et al., 2001).
The force-dependent dissociation rate of the a4b1/VCAM-1
(mutant) complexes computed using Eq. 4 and the derived
Bell model parameters are shown in Fig. 6, B and C. Under
pulling forces ,;50 pN, the dissociation rate is highly
sensitive to pulling forces and is governed principally by the
properties of the outer barrier (i.e., g2 and k
0
2). At stronger
forces, the dissociation rate is governed by the inner barrier
and is less responsive to changes in pulling force. In the
absence of the inner barrier, as seen when the Asp-40 residue
is mutated to Ala, the dissociation rate of the complex
continues to increase exponentially with pulling force. When
Asp-40 is mutated to Glu (D40E), the inner barrier remains,
though suppressed. As a result, the D40E mutant is expected
to show some force resistance above 50 pN. In contrast,
mutations that suppress just the outer barrier, as in the
D143A mutant, have a greater effect on the dissociation rate
of the complex at pulling forces ,50 pN.
It is worthwhile to compare the dynamic response of the
a4b1/VCAM-1 complex with other leukocyte adhesion
complexes involved in the extravasation and to relate the
intrinsic biophysical properties of the adhesion complexes to
their function at the cellular level. The process of leukocyte
extravasation involves multiple stages: rolling, cell activa-
tion, ﬁrm adhesion, and, ﬁnally, transmigration. Each stage
engages a different set of adhesion molecules (Springer,
1994). Leukocyte rolling is mediated mainly by the selectin
family molecules, whereas ﬁrm adhesion is mediated by the
activated integrins and their adhesive ligands (Kubes, 2002).
Speciﬁcally, the L-selectin/ligand and aLb2/ICAM-1 inter-
actions are known to mediate leukocyte rolling and ﬁrm
adhesion, respectively (Lawrence and Springer, 1991), while
the a4b1/VCAM-1 interaction could mediate both leukocyte
rolling and ﬁrm adhesion (Alon et al., 1995; Kubes, 2002).
Recently, the mechanical properties of the L-selectin/sLeX
complex and the aLb2/ICAM-1 complex were characterized
by single-molecule DFS (Evans et al., 2001; Zhang et al.,
2002), thus allowing for a comparison of the key molecular
components of leukocyte extravasation. An examination of
kinetic proﬁles of the three complexes revealed that the force-
dependent dissociation rate of the L-selectin/sLeX complex is
faster and more sensitive to a pulling force than the aLb2/
ICAM-1 complex (Fig. 7), suggesting that the L-selectin/
sLeX interaction is better suited for cell rolling because, in
this capacity the adhesion complex should be transient and
need to dissociate readily during cell rolling (Orsello et al.,
2001). Not surprisingly, the more force-resistant aLb2/
ICAM-1 complex is better suited for facilitating ﬁrm
adhesion. The kinetic proﬁle of the a4b1/VCAM-1 complex
provides a likely explanation of how this complex is able to
TABLE 2 Bell model parameters of the low and high afﬁnity a4b1/VCAM-1 complexes
Ligand-receptor pair Conditions g1(A˚) k
0
1ðs1Þ g2(A˚) k02ðs1Þ
Memb. a4b1/VCAM-1 Resting 0.93 6 0.06 63 6 10 5.2 6 0.3 1.1 6 0.2
TS2/16 0.99 6 0.03 75 6 5 6.2 6 0.6 0.04 6 0.02
a4b1-Fc/VCAM-1 Mg
21 1.0 6 0.1 59 6 7 5.9 6 0.2 0.13 6 0.02
The Bell model parameters were given by ﬁtting Eq. 3 to the acquired measurements. Linear regression was done using IgorPro software. The indices 1 and 2
in the subscript of the Bell model parameters refer to the inner and outer barriers of the complex, respectively. The goodness of ﬁt was determined by R2, the
square of the correlation coefﬁcient. An R2 of 0.95 was chosen as the cutoff point to determine the transition point between the slow and the fast loading
regimes.
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mediate both cell rolling and ﬁrm adhesion. As revealed in
Fig. 7, the dissociation kinetics of a4b1/VCAM-1 bond re-
sembles more the kinetic proﬁle of the L-selectin/sLeX
complex at pulling force.;50pN.However, at weak pulling
forces, the off rate of the a4b1/VCAM-1 bond is comparable
to that of the aLb2/ICAM-1 complex. Previous ﬂow-chamber
experiments revealed that the shear force exerted on a single
selectin bond ranged between 50 and 250 pN (Chen and
Springer, 2001; Smith et al., 1999). In this force region, the
mechanical properties of the a4b1/VCAM-1 bond resemble
the selectin bond and are suitable for rolling. However, when
the leukocyte is activated and more integrin complexes
are formed, the pulling force shared by individual a4b1/
VCAM-1 complex may be,50 pN. Within this force range,
the off rate of the a4b1/VCAM-1 complex is similar to the
aLb2/ICAM-1 bond and thus capable of facilitating ﬁrm
adhesion.
In summary, DFS of the a4b1/VCAM-1 complexes reveal
that the dissociation of this complex involves overcoming at
least two activation barriers. As a result of the steep inner
barrier, the complex is less sensitive to large pulling forces.
Using the VCAM-1 mutants, we found that the Asp-40
residue directly forms the inner activation barrier by in-
teracting with the chelated Mg21 ion, and that the C-D loop
participates in the generation of the outer barrier and helps
maintain the inner barrier. The kinetic proﬁle of the a4b1/
VCAM-1 complex shows similarity to the L-selectin/sLeX
complex in strong pulling forces, but its off rates resemble
the aLb2/ICAM-1 complex in lower pulling forces. This
special kinetic proﬁle may reﬂect a biophysical basis that
permits a dual physiological function (i.e., cell rolling and
ﬁrm adhesion) of the a4b1/VCAM-1 interaction.
FIGURE 7 Kinetic proﬁles for the high-afﬁnity a4b1/VCAM-1, L-selectin/
sLeX and high-afﬁnity aLb2/ICAM-1 interactions. The force-dependent
dissociation rate of the complex was given by Eq. 4. Bell model parameters for
the L-selectin/sLeX and high-afﬁnity aLb2/ICAM-1 complexes were obtained
from Evans et al. (2001) and Zhang et al. (2002), respectively.
FIGURE 6 Energy and kinetic proﬁles of the a4b1/VCAM-1 (mutant)
complexes. (A) Dissociation potential of the a4b1/VCAM-1 interaction. The
forced dissociation of the a4b1/VCAM-1 bond involves overcoming two
activation energy barriers. Positions and energies of the transition states of
the a4b1/wild-type VCAM-1, and a4b1/VCAM-1 mutant complexes are
shown. (B and C) Kinetic proﬁles of the a4b1/VCAM-1 mutant complexes.
(B) Effect of mutations in the Asp-40 residue. (C) Effect of mutations at the
C-D loop of D1 or at the Asp-143 residue of D2 of VCAM-1. The force-
dependent dissociation rate of the complex was given by Eq. 4.
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